MUPIROCIN | A065192 | FOUGERA PHARMACEUTICALS INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Teligent, Inc. FDA-2016-P-4274 · 4 docket documents Teligent, Inc. filed this citizen petition under Section 505(j) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA designate Mupirocin Ointment 2% ANDA 065192, held by Fougera Pharmaceuticals, Inc., as a second reference-listed drug in the Orange Book, because the currently designat | 505(q) | 2016-12-08 | Partially Denied | Teligent, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.